PDCD1 and acute lymphoblastic leukemia: In ALL patients, the proportion of CD4+ PD1+ T lymphocytes significantly decreased (p = 0.0165, Fig. 4C), while CD8+ PD1+ showed a declining trend after treatment, albeit without statistical significance (p = 0.0806, Fig. 4D).